Companies/US/NVCR

NOVOCURE LIMITED

Last · —$13.84-0.46 (-3.22%)live · yahoo · 45m ago
Vol 335.6K ≈ 4.76M
Market cap$1.61B—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session

Issuer

Legal nameNOVOCURE LIMITED
HQUnited States (US)
ListingUS NVCR
ISINJE00BYSS4X48
SectorHealthcare
IndustryHealthcare Products
SIC3841
CurrencyUSD
Entity registrysec:0001645113
CIK0001645113
LinkedIn
Employees1,605
AddressNovoCure Ltd. No. 4 The Forum JE2 4UF, St. Helier
Headline financial metrics
Revenue$357.6M
Operating income$-78.0M
Net income$-86.8M
Free cash flow$-17.5M
Operating margin-21.8%
Net margin-24.3%
Return on equity-25.7%
Period2026
Loading chart…

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.23
Est. revenue
182.2M

Documents

FormReporting forFiledFlags
2026-06-302026-07-23 5